liarozole has been researched along with Hormone-Dependent Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Coster, R; Debruyne, FM; Dijkman, GA; Schalken, JA; Van Ginckel, R; Van Moorselaar, RJ; Van Stratum, P; Wouters, L | 1 |
| Denis, L | 1 |
1 trial(s) available for liarozole and Hormone-Dependent Neoplasms
| Article | Year |
|---|---|
European Organization for Research and Treatment of Cancer (EORTC) prostate cancer trials, 1976-1996.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Castration; Cyproterone Acetate; Diethylstilbestrol; Doxorubicin; Epirubicin; Estramustine; Flutamide; Humans; Imidazoles; Male; Medroxyprogesterone Acetate; Methotrexate; Mitomycin; Neoplasms, Hormone-Dependent; Procarbazine; Prostatic Neoplasms; Vindesine | 1998 |
1 other study(ies) available for liarozole and Hormone-Dependent Neoplasms
| Article | Year |
|---|---|
Antitumoral effects of liarozole in androgen-dependent and independent R3327-Dunning prostate adenocarcinomas.
Topics: Adenocarcinoma; Androgens; Animals; Antineoplastic Agents; Imidazoles; Male; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Rats; Tumor Cells, Cultured | 1994 |